2026 NPPES data Pediatric Ophthalmology and Strabismus Specialist Physician NPI 1861027815 MD
Verify on CMS →

ROBERT ROBBINS, MD

Pediatric Ophthalmology and Strabismus Specialist Physician in CHICAGO, Illinois. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
635
Medicare Part D claims · 222 beneficiaries · Pediatric Ophthalmology and Strabismus Specialist Physician avg: 266
Generic prescribing
61%
generic claims · 39% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$2.1K
20 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

ROBERT ROBBINS, MD filed 635 Medicare Part D claims in 2023 as a Pediatric Ophthalmology and Strabismus Specialist Physician in CHICAGO, Illinois, prescribing 61% generic.

635
Part D claims, 2023
61%
generic prescribing
$2.1K
industry payments (Sunshine Act)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

ROBERT ROBBINS, MD's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

635 Top 31% higher than 69% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). Below this entry. 600–800: 56,224 prescribers (4%). This entry sits in this band. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board-eligible specialty (heuristic — not verified)

ROBERT ROBBINS, MD practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about ROBERT ROBBINS, MD?

Quality data not reported

NPI registry status

Active

Issued 03/10/2020

NPI 1861027815

Primary specialty

Pediatric Ophthalmology and Strabismus Specialist Physician

Rare

242 US NPIs in this specialty

Medicare Part D claims

635 139% vs specialty avg

2023 prescription claims

Specialty avg: 266

Specialty distribution in Illinois

How Pediatric Ophthalmology and Strabismus Specialist Physician compares to other specialties among Illinois providers

Illinois providers

Pediatric Ophthalmology and Strabismus Specialist Physician share within Illinois

1. Pediatric Ophthalmology and Strabismus Specialist Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Pediatric Ophthalmology and Strabismus Specialist Physician share within Illinois

Specialty board-certification context

Estimated specialty board-certified rate — Pediatric Ophthalmology and Strabismus Specialist Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Pediatric Ophthalmology and Strabismus Specialist Physician ABMS/AOA estimate

Est. board-certified rate (Pediatric Ophthalmology and Strabismus Specialist Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Pediatric Ophthalmology and Strabismus Specialist Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

ROBERT ROBBINS, MD appears in the CMS NPPES registry as a Pediatric Ophthalmology and Strabismus Specialist Physician provider holding MD credentials at 225 E CHICAGO AVE, CHICAGO, IL, 60611, with a listed phone of (800) 543-7362. NPI 1861027815 was issued on 03/10/2020. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what ROBBINS most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 635 prescription claims written by this provider, covering 222 Medicare beneficiaries and totaling roughly $164K in drug spend, split 39% brand-name and 61% generic by claim count, with an opioid prescribing rate of 2.4%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Pediatric Ophthalmology and Strabismus Specialist Physician is a narrow specialty nationwide, with 242 enrolled providers across 40 states and an average of 266 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

225 E CHICAGO AVE
CHICAGO, IL 60611

Provider Details

NPI 1861027815
Specialty Pediatric Ophthalmology and Strabismus Specialist Physician
Credentials MD
Gender Male
NPI Issued 03/10/2020

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for ROBERT ROBBINS, MD. Source: openpaymentsdata.cms.gov.

Total received

$2.1K

Largest payer

Alcon Vision LLC

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Illinois IDFPR 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~42K Illinois medical licensees in 2023 — they are NOT specific to ROBERT ROBBINS, MD. To verify ROBERT ROBBINS, MD's current license status, search the IDFPR public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

106
Total board actions, Illinois 2023
Across 103 cases
2.52
Actions per 1,000 licensees
Illinois statewide rate
probation
Most common action type
38 cases

IDFPR publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Illinois disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Above average

ROBERT ROBBINS, MD — brand share 39.0%
Specialty average (est.)

39% brand-name claims vs 61% generic, on 635 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

635
Total Claims
$164K
Total Drug Cost
222
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
910
Total Day Supply
22,311
Brand vs Generic
39% brand / 61% generic
Brand Drug Cost
$153K
Generic Drug Cost
$11K
Opioid Claims
15 (2.4% rate)
Antibiotic Claims
22

Patient Demographics

Average Patient Age
70.0 years
Avg HCC Risk Score
1.71
Gender Split
65% female / 35% male
Age Distribution
<65: 40, 65-74: 110, 75-84: 55, 85+: 17

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What ROBERT ROBBINS, MD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Prednisolone Acetate
98
Moxifloxacin
Moxifloxacin Hcl
81
Latanoprost
53
Erythromycin
Erythromycin Base
42
Ketorolac Tromethamine
42
Dorzolamide-Timolol
Dorzolamide Hcl/Timolol Maleat
29
Neomycin-Polymyxin-Dexameth
Neomycin/Polymyxin B/Dexametha
27
Brimonidine Tartrate
25
Restasis
Cyclosporine
24
Timolol Maleate
22

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Pediatric Ophthalmology and Strabismus Specialist Physician Overview

How ROBERT ROBBINS, MD fits within the Pediatric Ophthalmology and Strabismus Specialist Physician landscape nationally.

242
Pediatric Ophthalmology and Strabismus Specialist Physician Providers in US
40
States with Pediatric Ophthalmology and Strabismus Specialist Physician
266
Avg Claims per Provider

ROBERT ROBBINS, MD's 635 claims are above the specialty average of 266.

Nearby Pediatric Ophthalmology and Strabismus Specialist Physician Providers in Illinois

Other clinicians with the same primary specialty enrolled in Illinois, drawn from the same CMS NPPES roster as ROBBINS.

Compare Pediatric Ophthalmology and Strabismus Specialist Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is ROBERT ROBBINS, MD's specialty?
ROBERT ROBBINS, MD specializes in Pediatric Ophthalmology and Strabismus Specialist Physician and practices in CHICAGO, Illinois. Credentials: MD.
How much does ROBERT ROBBINS, MD prescribe under Medicare Part D?
In 2023, ROBERT ROBBINS, MD wrote 635 Medicare Part D claims totaling $164K in drug costs for 222 beneficiaries.
Where is ROBERT ROBBINS, MD located?
ROBERT ROBBINS, MD is located at 225 E CHICAGO AVE, CHICAGO, IL, 60611. Phone: (800) 543-7362.
What is ROBERT ROBBINS, MD's NPI number?
ROBERT ROBBINS, MD's National Provider Identifier (NPI) is 1861027815, issued on 03/10/2020.
Does ROBERT ROBBINS, MD prescribe more brand-name or generic drugs?
ROBERT ROBBINS, MD's prescribing is 39% brand-name and 61% generic drugs by claim count, with $153K in brand drug costs.
Does ROBERT ROBBINS, MD prescribe opioids?
Yes, ROBERT ROBBINS, MD had 15 opioid claims in 2023 with an opioid prescribing rate of 2.4%.
How many Pediatric Ophthalmology and Strabismus Specialist Physician providers are there in the US?
There are 242 Pediatric Ophthalmology and Strabismus Specialist Physician providers across 40 states in the US. The average Pediatric Ophthalmology and Strabismus Specialist Physician provider writes 266 Medicare Part D claims per year.
What drugs does ROBERT ROBBINS, MD prescribe most often?
Based on 2023 Medicare Part D data, ROBERT ROBBINS, MD's most frequently prescribed drugs include Prednisolone Acetate, Moxifloxacin, Latanoprost. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does ROBERT ROBBINS, MD accept Medicare?
ROBERT ROBBINS, MD appears in CMS Medicare data with 635 Part D claims and 222 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify ROBERT ROBBINS, MD's credentials?
ROBERT ROBBINS, MD's NPI is 1861027815 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology